The WHO in April launched the Access to COVID-19 Tools Accelerator, a global collaboration and fund that has a goal of advancing the development, production and equitable access to COVID-19 treatments and diagnostics.
However, Dr. Ghebreyesus said that billions more dollars are needed to realize the promise of it.
About $9.9 billion has been pledged to date, according to the report. Dr. Ghebreyesus said that the funding needed for vaccines alone was more than $100 billion.
“We have to fundamentally scale up the way we are financing the ACT-Accelerator and prioritize the use of new tools,” Dr. Ghebreyesus said, according to CNBC.
More articles on healthcare finance:
How much CARES Act cash went to HCA, CHS + UHS in Q2
Tenet to end some inpatient services at 2 Massachusetts hospitals
Steward directed staff to delay payments to vendors, former controller says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
